Literature DB >> 33378097

A Healthcare System-Level Intervention to Increase Naloxone Availability for Patients With Opioid Prescriptions.

Jonathan E Siff1,2, David Margolius1,2, Joan Papp1,2, Bernard Boulanger1,2, Brook Watts1,2.   

Abstract

BACKGROUND AND OBJECTIVES: National guidelines recommend prescribing naloxone to patients receiving chronic opioids. However, provider adherence to naloxone co-prescribing best practices is poor and knowledge gaps for improvement efforts are large. As part of a system-wide quality improvement intervention to improve opioid safety, we sought to improve access to naloxone for patients with opioid prescriptions.
METHODS: A prompt for naloxone co-prescribing was implemented in the electronic health record. Baseline data and data after implementation were collected for naloxone co-prescribing and fill rates on naloxone prescriptions s (n = 9122 pre, 8368 post).
RESULTS: In the 9 months following the implementation of the electronic prompt, the total number of naloxone prescriptions increased more than 15-fold. Patients prescribed naloxone filled their naloxone prescriptions similarly (42%) before and after the prompt implementation, resulting in a marked increase in the absolute number of patients with access to naloxone. Patient fill rates varied by clinical area (33% emergency medicine to 47% general medicine). CONCLUSION AND SCIENTIFIC SIGNIFICANCE: An electronic prompt, encouraging providers to prescribe naloxone to at-risk patients led to a marked increase in the percentage of patients with an active naloxone prescription. The availability of naloxone in communities saves lives and this study is the first to demonstrate an intervention, which led to increased naloxone prescribing and reported on actual pharmacy fills of naloxone when co-prescribed with opioids. (Am J Addict 2020;00:00-00).
© 2020 American Academy of Addiction Psychiatry.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33378097     DOI: 10.1111/ajad.13136

Source DB:  PubMed          Journal:  Am J Addict        ISSN: 1055-0496


  4 in total

1.  Pharmacy naloxone codispensing: A mixed methods study of practices and perspectives under a statewide standing order program.

Authors:  Robin A Pollini; Susannah Slocum; Jenny E Ozga; Rebecca Joyce; Ziming Xuan; Traci C Green; Alexander Y Walley
Journal:  J Am Pharm Assoc (2003)       Date:  2022-03-19

2.  Enhancing research data infrastructure to address the opioid epidemic: the Opioid Overdose Network (O2-Net).

Authors:  Leslie A Lenert; Vivienne Zhu; Lindsey Jennings; Jenna L McCauley; Jihad S Obeid; Ralph Ward; Saeed Hassanpour; Lisa A Marsch; Michael Hogarth; Perry Shipman; Daniel R Harris; Jeffery C Talbert
Journal:  JAMIA Open       Date:  2022-06-30

3.  A longitudinal study of naloxone opioid overdose awareness and reversal training for first-year medical students: specific elements require reinforcement.

Authors:  Reena K Sandhu; Michael V Heller; Jack Buckanavage; Benjamin Haslund-Gourley; Joshua Leckron; Brady Kupersmith; Nathaniel C Goss; Kyle Samson; Annette B Gadegbeku
Journal:  Harm Reduct J       Date:  2022-07-02

4.  Naloxone prescribing practices in the Military Health System before and after policy implementation.

Authors:  Jennifer Pakieser; Sidney Peters; Laura C Tilley; Ryan C Costantino; Maya Scott-Richardson; Krista B Highland
Journal:  Pain Rep       Date:  2021-03-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.